What Is Responsible for Heterogeneity in Mantle Cell Lymphoma Biology and Outcomes?

Mantle cell lymphoma, despite its common derivation from a t(11;14) error that occurs in a na ïve B-cell leading to overexpression of cyclin D1 protein, is characterized by substantial heterogeneity in biology and clinical outcome. Unlike other non-Hodgkin lymphoma types, it is more common in men. Clinical presentation patterns vary from nodal to splenomegaly with leukemia to gastrointestin al involvement. Biological variability is linked to tumor cell proliferation. Increased monocyte/macrophages and their associated proinflammatory cytokines are associated with inferior outcomes. These clues mandate that new treatments should target signal pathways that contribute to these adverse ou tcomes.
Source: Hematology/Oncology Clinics of North America - Category: Cancer & Oncology Authors: Source Type: research